Nicole A. Shonka, M.D., and Mark R. Gilbert, M.D.
Dr Shonka is a Fellow and Dr. Gilbert is the Deputy Chair and Professor, the Department of Neuro-Oncology, the University of Texas M.D. Anderson Cancer Center, Houston, TX.
Within the past 12 months, Dr. Shonka reports no commercial conflicts of interest, while Dr. Gilbert has received grant/research support from Genentech and Schering-Plough, and been a consultant to Genentech, Pfizer and Schering-Plough.
Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.
Release Date: 02/22/2010
Upon completion of this Cyberounds®, you should be able to:
Highlight pathways important in gliomagenesis
Discuss the current use of molecularly targeted agents for gliomas, as well as efficacy and adverse effects of treatment
Discuss the ongoing research using targeted agents in the treatment of gliomas.
